GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Obalon Therapeutics Inc (NAS:OBLN) » Definitions » Tax Rate %

Obalon Therapeutics (Obalon Therapeutics) Tax Rate % : 0.00% (As of Mar. 2021)


View and export this data going back to 2016. Start your Free Trial

What is Obalon Therapeutics Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Obalon Therapeutics's Tax Expense for the three months ended in Mar. 2021 was $0.00 Mil. Obalon Therapeutics's Pre-Tax Income for the three months ended in Mar. 2021 was $-4.17 Mil. Therefore, Obalon Therapeutics's Tax Rate % for the quarter that ended in Mar. 2021 was 0.00%.


Obalon Therapeutics Tax Rate % Historical Data

The historical data trend for Obalon Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Obalon Therapeutics Tax Rate % Chart

Obalon Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Tax Rate %
Get a 7-Day Free Trial - - - - -

Obalon Therapeutics Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Obalon Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Obalon Therapeutics's Tax Rate % for the fiscal year that ended in Dec. 2020 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2020 )/Pre-Tax Income (A: Dec. 2020 )
=0/-12.334
=0.00 %

Obalon Therapeutics's Tax Rate % for the quarter that ended in Mar. 2021 is calculated as

Tax Rate %=Tax Expense (Q: Mar. 2021 )/Pre-Tax Income (Q: Mar. 2021 )
=0/-4.167
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Obalon Therapeutics Tax Rate % Related Terms

Thank you for viewing the detailed overview of Obalon Therapeutics's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.


Obalon Therapeutics (Obalon Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
5421 Avenida Encinas, Suite F, Carlsbad, CA, USA, 92008
Obalon Therapeutics Inc is a medical device company that focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes Obalon Balloon System. Geographically, it derives all of its revenue from the United States.
Executives
Raymond V Dittamore director P O BOX 2050, GLENWOOD SPRINGS CO 81602
William J. Plovanic director C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Sharon Stevenson director C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ECINAS, SUITE F, CARLSBAD CA 92008
Douglas Fisher director 587 PATROL RD, WOODSIDE CA 94062
Lesley H Howe director
Kim P. Kamdar director C/O DOMAIN ASSOCIATES, L.L.C., ONE PALMER SQUARE, SUITE 515, PRINCETON NJ 08542
Andrew P Rasdal director, officer: President, CEO & Exec Chairman C/O DEXCOM, INC., 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Nooshin Hussainy officer: Chief Financial Officer C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Mark Brister officer: Chief Technology Officer C/O DEXCOM, INC., 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Robert J Macdonald officer: Chief Retail Officer C/O OBALON THERAPEUTICS INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Amy Vandenberg officer: Chief Clinical & Reg Officer C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Nicole Vitullo 10 percent owner 3030 SCIENCE PARK ROAD, SAN DIEGO CA 92121
Brian H Dovey 10 percent owner ONE PALMER SQUARE, PRINCETON NJ 08542
Arnold L Oronsky 10 percent owner C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022
Gilbert H Kliman 10 percent owner C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022

Obalon Therapeutics (Obalon Therapeutics) Headlines